Discovery of an autophagy inducer J3 to lower mutant huntingtin and alleviate Huntington’s disease-related phenotype
Open Access
- 8 October 2022
- journal article
- research article
- Published by Springer Nature in Cell & Bioscience
- Vol. 12 (1) , 1-16
Abstract
Huntington’s disease (HD) is a neurodegenerative disorder caused by aggregation of the mutant huntingtin (mHTT) protein encoded from extra tracts of CAG repeats in exon 1 of the HTT gene. mHTT proteins are neurotoxic to render the death of neurons and a series of disease-associated phenotypes. The mHTT is degraded through autophagy pathway and ubiquitin–proteasome system (UPS). This study identified a small molecule, J3, as an autophagy inducer by high-content screening. The results revealed that J3 could inhibit mTOR, thus promoting autophagic flux and long-lived protein degradation. Further, J3 selectively lowered the soluble and insoluble mHTT but not wild type HTT levels in cell models. The HdhQ140 mice showed reduced HD-associated activity and loss of motor functions. However, administration of J3 showed increased activity and a slight improvement in the motor function in the open-field test, balance beam test, and rotarod tests. Furthermore, in vivo studies revealed that J3 decreased T-HTT and misfolded protein levels in the striatum and increased the levels of the medium spiny neuron marker DARPP-32. In addition, J3 showed good permeability across the brain-blood barrier efficiently, suggesting that J3 was a promising candidate for the treatment of HD.Keywords
This publication has 42 references indexed in Scilit:
- Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathwayAutophagy, 2011
- Chemical Inducers of Autophagy That Enhance the Clearance of Mutant Proteins in Neurodegenerative DiseasesJournal of Biological Chemistry, 2010
- Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathiesCell Death & Differentiation, 2008
- Small molecules enhance autophagy and reduce toxicity in Huntington's disease modelsNature Chemical Biology, 2007
- Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brainJournal of Neurochemistry, 2006
- Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathwayJournal of Cell Biology, 2006
- Lithium induces autophagy by inhibiting inositol monophosphataseJournal of Cell Biology, 2005
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004
- Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington diseaseNature Genetics, 2004
- Time course of early motor and neuropathological anomalies in a knock‐in mouse model of Huntington's disease with 140 CAG repeatsJournal of Comparative Neurology, 2003